D
Stoke Therapeutics, Inc. STOK
$19.56 -$0.12-0.61% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 186.01% 3,661.12% 707.07% 47.94% 294.72%
Total Other Revenue -- -- -- -- --
Total Revenue 186.01% 3,661.12% 707.07% 47.94% 294.72%
Cost of Revenue -- -- -- -- --
Gross Profit 186.01% 3,661.12% 707.07% 47.94% 294.72%
SG&A Expenses 17.07% 43.38% 21.06% 23.57% 27.44%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 20.32% 45.23% 11.98% 14.26% 11.02%
Operating Income 6.96% 492.08% 53.85% -10.17% 11.79%
Income Before Tax 8.61% 532.84% 61.12% -7.69% 16.18%
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations 8.61% 527.99% 61.12% -7.69% 16.18%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 8.61% 527.99% 61.12% -7.69% 16.18%
EBIT 6.96% 492.08% 53.85% -10.17% 11.79%
EBITDA 6.74% 501.73% 54.68% -10.78% 11.81%
EPS Basic 12.67% 442.07% 69.35% 15.39% 33.57%
Normalized Basic EPS 12.67% 445.99% 69.34% 15.38% 33.58%
EPS Diluted 12.67% 433.16% 69.35% 15.39% 33.57%
Normalized Diluted EPS 12.67% 437.04% 69.34% 15.38% 33.58%
Average Basic Shares Outstanding 4.64% 25.12% 26.85% 27.28% 26.20%
Average Diluted Shares Outstanding 4.64% 28.44% 26.85% 27.28% 26.20%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --